- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00564252
Topical Finasteride in the Treatment of Idiopathic Hirsutism
November 26, 2007 updated by: Iran University of Medical Sciences
The Efficacy of Topical Finasteride in the Treatment of Idiopathic Hirsutism
the purpose of this study is to evaluate the efficacy of topical Finasteride in the treatment of idiopathic hirsutism
Study Overview
Study Type
Interventional
Enrollment (Actual)
56
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Idiopathic hirsutism which is defined as normal levels of androgens and normal ovulation
- Normal serum prolactin
Exclusion Criteria:
- Pregnancy
- Simultaneous use of other drugs for the treatment of hirsutism
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the efficacy of topical finasteride was determined by comparison of Ferriman-Gallwey score before and after medication
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the efficacy of topical finasteride was determined by comparison of mean hair thickness before and after medication
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: iraj heydari, professor assistant, endocrine and metabolism centre of Iran University of Medical Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2006
Study Completion (Actual)
October 1, 2006
Study Registration Dates
First Submitted
November 26, 2007
First Submitted That Met QC Criteria
November 26, 2007
First Posted (Estimate)
November 27, 2007
Study Record Updates
Last Update Posted (Estimate)
November 27, 2007
Last Update Submitted That Met QC Criteria
November 26, 2007
Last Verified
November 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Skin Diseases
- Hair Diseases
- Virilism
- Hirsutism
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Urological Agents
- Enzyme Inhibitors
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormone Antagonists
- Steroid Synthesis Inhibitors
- 5-alpha Reductase Inhibitors
- Finasteride
Other Study ID Numbers
- 84-5-6886
- IUMS127
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Idiopathic Hirsutism
-
Alexander ShayestehRecruitingHypertrichosis | Hirsutism - HypertrichosisSweden
-
Istanbul Medeniyet UniversityUnknown
-
Bispebjerg HospitalCompleted
-
Medical Life Care Planners, LLCNot yet recruitingHair Diseases | Hirsutism
-
NHS Greater Glasgow and ClydeUnknown
-
Combined Military Hospital AbbottabadCompleted
-
University of JenaUnknown
Clinical Trials on topical finasteride
-
Polichem S.A.CompletedAlopecia, AndrogeneticBelgium, Germany, Hungary, Russian Federation, Spain
-
University of FloridaWithdrawnFemale Androgenetic AlopeciaUnited States
-
GlaxoSmithKlineCompletedAndrogenetic AlopeciaJapan, Argentina, Peru, Philippines, Taiwan, Mexico, Chile, Russian Federation, Thailand
-
Elorac, Inc.Completed
-
Universidad de AntioquiaINNOVATION CORPORATION FOR THE DEVELOPMENT OF PRODUCTS FOR TROPICAL DISEASES... and other collaboratorsWithdrawnLeishmaniasis, CutaneousColombia
-
EMSRecruitingAndrogenetic AlopeciaBrazil
-
Hospices Civils de LyonUnknown
-
Polichem S.A.Completed
-
Novan, Inc.CompletedAcne VulgarisUnited States
-
Stanford UniversityUniversity of Pennsylvania; University of California, Davis; Oregon Health and... and other collaboratorsRecruiting